Recent advances in the field of obesity treatment have presented a innovative candidate known as ALLUVI Retatrutide. This compound is a {highlyeffective GLP-1 receptor agonist, engineered to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown significant outcomes in clinical trials, demonstrating significant losses in body w